Literature DB >> 21123970

BAFF-R is expressed on B-cell lymphomas depending on their origin, and is related to proliferation index of nodal diffuse large B-cell lymphomas.

Hiroyuki Takahata1, Nobuya Ohara, Kouichi Ichimura, Takehiro Tanaka, Yasuharu Sato, Toshiaki Morito, Katsuyoshi Takata, Masaru Kojima, Tetsuji Kobata, Tadashi Yoshino.   

Abstract

B-cell activating factor receptor (BAFF-R) is one of three known receptors for BAFF. BAFF-R is required for B-cell maturation and survival. We tried to determine the normal pattern of BAFF-R expression in non-neoplastic and neoplastic B- and T-cells. We used immunohistochemistry to evaluate the expression pattern of BAFF-R in non-neoplastic and neoplastic lymphoid tissues of routinely fixed paraffin-embedded samples, and examined the relationships among BAFF-R and expressions of CD10, bcl-6, MUM-1, and MIB-1. BAFF-R expression was detected on B-cells of the mantle zones, some cells within germinal centers, and scattered cells in the interfollicular areas of reactive lymph nodes. BAFF-R expression was only found in B-cell lymphoma (60/120, positive samples/examined samples), but not in T/NK cell lymphoma (0/10) or Hodgkin lymphoma (0/10). The proportions were as follows : follicular lymphoma (14/16), diffuse large B-cell lymphoma (DLBCL) (27/61), mantle cell lymphoma (4/4), and Burkitt lymphoma (0/4). According to Hans' criteria, DLBCLs were subclassified into germinal center B-cell-like (GCB) and non-germinal center B-cell-like (non-GCB) types. Interestingly, in nodal lymphomas, in the GCB subgroup (n=12), 9 of 12 (75%) were positive for BAFF-R, while 6 of 20 (30%) were positive in the non-GCB subgroup (n=20) (p < 0.05). In addition, expression of BAFF-R related to lower MIB-1 index was associated with GCB-type DLBCL. In conclusion, BAFF-R was only found in some B-cell lymphomas, which was closely associated with the expression pattern in normal counterparts, although BAFF-R expression on follicular lymphoma is different from that on germinal center cells, which is similar to bcl-2. BAFF-R was rather specifically related to low growth activity of GCB-type DLBCL of nodal origin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21123970     DOI: 10.3960/jslrt.50.121

Source DB:  PubMed          Journal:  J Clin Exp Hematop        ISSN: 1346-4280


  4 in total

1.  FBXO10 deficiency and BTK activation upregulate BCL2 expression in mantle cell lymphoma.

Authors:  Y Li; M N Bouchlaka; J Wolff; K M Grindle; L Lu; S Qian; X Zhong; N Pflum; P Jobin; B S Kahl; J C Eickhoff; S M Wuerzberger-Davis; S Miyamoto; C J Thomas; D T Yang; C M Capitini; L Rui
Journal:  Oncogene       Date:  2016-05-09       Impact factor: 9.867

Review 2.  CAR-T Cells Shoot for New Targets: Novel Approaches to Boost Adoptive Cell Therapy for B Cell-Derived Malignancies.

Authors:  Katsiaryna Marhelava; Marta Krawczyk; Malgorzata Firczuk; Klaudyna Fidyt
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

3.  DYRK1a mediates BAFF-induced noncanonical NF-κB activation to promote autoimmunity and B-cell leukemogenesis.

Authors:  Yanchuan Li; Xiaoping Xie; Zuliang Jie; Lele Zhu; Jin-Young Yang; Chun-Jung Ko; Tianxiao Gao; Antrix Jain; Sung Yun Jung; Natalia Baran; Marina Y Konopleva; Xuhong Cheng; Shao-Cong Sun
Journal:  Blood       Date:  2021-12-09       Impact factor: 22.113

Review 4.  Aptamers and Antisense Oligonucleotides for Diagnosis and Treatment of Hematological Diseases.

Authors:  Valentina Giudice; Francesca Mensitieri; Viviana Izzo; Amelia Filippelli; Carmine Selleri
Journal:  Int J Mol Sci       Date:  2020-05-04       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.